- Home
- CCRN vs MREO Comparison
CCRN vs MREO Comparison
Compare CCRN & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCRN
- MREO
- Stock Information
- Founded
- CCRN 1986
- MREO 2015
- Country
- CCRN United States
- MREO United Kingdom
- Employees
- CCRN N/A
- MREO N/A
- Industry
- CCRN Professional Services
- MREO Biotechnology: Pharmaceutical Preparations
- Sector
- CCRN Consumer Discretionary
- MREO Health Care
- Exchange
- CCRN Nasdaq
- MREO Nasdaq
- Market Cap
- CCRN 416.5M
- MREO 577.6M
- IPO Year
- CCRN N/A
- MREO N/A
- Fundamental
- Price
- CCRN $13.25
- MREO $4.56
- Analyst Decision
- CCRN Buy
- MREO Strong Buy
- Analyst Count
- CCRN 6
- MREO 4
- Target Price
- CCRN $19.60
- MREO $7.50
- AVG Volume (30 Days)
- CCRN 1.3M
- MREO 628.8K
- Earning Date
- CCRN 10-30-2024
- MREO 11-13-2024
- Dividend Yield
- CCRN N/A
- MREO N/A
- EPS Growth
- CCRN N/A
- MREO N/A
- EPS
- CCRN 0.25
- MREO N/A
- Revenue
- CCRN $1,575,271,000.00
- MREO $1,000,000.00
- Revenue This Year
- CCRN N/A
- MREO $16.39
- Revenue Next Year
- CCRN N/A
- MREO $9.44
- P/E Ratio
- CCRN $53.67
- MREO N/A
- Revenue Growth
- CCRN N/A
- MREO N/A
- 52 Week Low
- CCRN $12.00
- MREO $1.59
- 52 Week High
- CCRN $23.64
- MREO $5.02
- Technical
- Relative Strength Index (RSI)
- CCRN 51.14
- MREO 59.76
- Support Level
- CCRN $12.22
- MREO $3.94
- Resistance Level
- CCRN $12.65
- MREO $4.50
- Average True Range (ATR)
- CCRN 0.49
- MREO 0.20
- MACD
- CCRN 0.07
- MREO 0.04
- Stochastic Oscillator
- CCRN 75.30
- MREO 88.57
About CCRN Cross Country Healthcare Inc. $0.0001 Par Value
Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement, and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).